Dr. Salas Fragomeni is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1825 Logan Ave
Waterloo, IA 50703Phone+1 319-235-3941
Education & Training
Johns Hopkins UniversityResidency, Radiology-Diagnostic, 2016 - 2020
University of Washington School of MedicineClass of 2018- Johns Hopkins UniversityResidency, Nuclear Medicine, 2015 - 2016
- University of WashingtonResidency, Surgery, 2013 - 2015
Certifications & Licensure
IA State Medical License 2020 - 2026
WA State Medical License 2013 - 2015- American Board of Nuclear Medicine Nuclear Medicine
- American Board of Radiology Diagnostic Radiology
Publications & Presentations
PubMed
- 104 citationsImaging of Nonprostate Cancers Using PSMA-Targeted Radiotracers: Rationale, Current State of the Field, and a Call to ArmsRoberto A. Salas Fragomeni, Tali Amir, Sara Sheikhbahaei, Susan C. Harvey, Mehrbod S. Javadi
Journal of Nuclear Medicine. 2018-06-01 - 44 citations18 F-NaF-PET/CT for the detection of bone metastasis in prostate cancer: a meta-analysis of diagnostic accuracy studiesSara Sheikhbahaei, Krystyna M. Jones, Rudolf A. Werner, Roberto A. Salas-Fragomeni, Charles Marcus
Annals of Nuclear Medicine. 2019-03-15 - 62 citationsImmunomodulation by Entinostat in Renal Cell Carcinoma Patients Receiving High-Dose Interleukin 2: A Multicenter, Single-Arm, Phase I/II Trial (NCI-CTEP#7870).Roberto Pili, David I. Quinn, Hans J. Hammers, J. Paul Monk, Saby George
Clinical Cancer Research. 2017-12-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
